Publication of trial sites in result reports of clinical trials pursuant to Section 42b German Medicinal Products Act (Arzneimittelgesetz, AMG) – Amended version of 19 June 2020 –
Updated joint information from the Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM) and the Paul-Ehrlich-Institut,
Federal Institute for Vaccines and Biomedicines (Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel, PEI)
2020.07.21
Updated joint information from the BfArM and PEI on the publication of trial sites in result reports of clinical trials pursuant to Section 42b German Medicinal Products Act (Arzneimittelgesetz, AMG)